Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics Revenue

Aquestive Therapeutics had revenue of $13.54M in the quarter ending September 30, 2024, with 4.15% growth. This brings the company's revenue in the last twelve months to $58.90M, up 22.56% year-over-year. In the year 2023, Aquestive Therapeutics had annual revenue of $50.58M with 6.09% growth.

• Revenue (ttm): $58.90M
• Revenue Growth: +22.56%
• P/S Ratio: 6.59
• Revenue / Employee: $436,296
• Employees: 135
• Market Cap: 416.23M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	50.58M	2.90M	6.09%
Dec 31, 2022	47.68M	-3.15M	-6.20%
Dec 31, 2021	50.83M	4.98M	10.87%
Dec 31, 2020	45.85M	-6.76M	-12.85%
Dec 31, 2019	52.61M	-14.82M	-21.98%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.